SANTSARAN PATEL: Open Payments
NPI 1316960016 · SIERRA VISTA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$384 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $384
Food & beverage: $384
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Amgen Inc. | 4 | $65 |
| ABBVIE INC. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $39 |
| Novo Nordisk Inc | 2 | $38 |
| Lilly USA, LLC | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: CAPLYTA, Veozah, Rybelsus, EVENITY, KISUNLA, AIRSUPRA, SYNTHROID, VOQUEZNA.
Industry payments across AZ — which companies pay providers there.
